Statin use linked to lower risk of frailty in older adults

Clinical Takeaway: Statins may offer benefits beyond cardiovascular disease prevention. In older adults at risk for frailty, statin therapy may help preserve function and independence while addressing cardiovascular risk factors.

Frailty is a common and often devastating condition in older adults, increasing vulnerability to disability, hospitalization, and loss of independence. Despite its substantial burden, there are currently no approved medications specifically aimed at preventing frailty.

In a large study of nearly one million US veterans aged 67 years and older, investigators examined whether starting statin therapy was associated with a lower risk of developing frailty. All participants were non-frail and statin-naive at baseline.

Over an average follow-up of 5.3 years, statin initiation was associated with a 24% lower risk of developing frailty compared with nonuse. The association remained consistent across multiple patient groups, including those with diabetes, cardiovascular disease, arthritis, and dementia.

Similar results were seen among participants who were already considered pre-frail at baseline, suggesting that potential benefits may extend to patients who've begun to show early signs of functional decline.

The results are notable because frailty and cardiovascular disease share many underlying biologic mechanisms, including inflammation and metabolic dysfunction. Statins may influence some of these pathways in addition to their established cholesterol-lowering effects.

“While randomized trials are needed, these observational findings suggest a potential role for statins in preventing frailty,” said senior author Ariela Orkaby, MD, MPH. “We know that frailty and heart disease share underlying mechanisms. Our study suggests that targeting those mechanisms could help prevent both outcomes.”

Source: Qazi S, et al. 2026 June 10. Eur Heart J. Statins and survival free of incident frailty among older US veterans